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SUPPLEMENTAL MATERIAL 
ZBTB17 (MIZ1) is important for the cardiac stress response and a novel 
candidate gene for cardiomyopathy and heart failure 
 
Supplemental Methods 
Yeast two-hybrid, Immunoprecipitation and Western blots 
A Matchmaker Gal4 two-hybrid system 3 (Clontech) was used for interaction analyses and an 
adult mouse heart library was screened. A total of 10
6
 clones were screened, all 650 positive 
clones were isolated, transformed and sequenced following the manufacturer’s instructions. 
Among the positive clones were cDNAs encoding alpha actinin, a previously known CSRP3 
interacting protein or telethonin (TCAP)
1-3
. We also identified a clone encoding the 5’ sequence 
of Zbtb17.  
Mouse heart tissue (WT) was homogenized in ice-cold RIPA buffer containing 10 mM Tris, 
pH7.4, 150 mM NaCl, 0.2% Triton X-100, 2mM EDTA, 1 mM PMSF, plus 1× protease inhibitor 
mixture. The heart lysate was centrifuged at 3000 rpm for 10 min at 4°C, and the supernatant 
collected. 1 mg of total protein was pre-cleared by addition of 100 μl of 1:1 slurry of protein A 
sepharose beads for 1 hr at 4°C on rotivator and centrifuged at 3000 rpm for 1 min at 4°C. The 
resulting supernatants were transferred to fresh tubes, and 10 μl of anti-ZBTB17 antibody (Santa 
Cruz H-190; sc 22837) was added and incubated overnight at 4°C on a rotivator. After 
incubation, 100 μl of 1:1 slurry of protein A sepharose beads was added to each sample to collect 
the immunocomplex, and the mixture of lysate and beads was incubated for 2 hrs at 4°C. 
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Immune precipitates were then washed 3 times with cold lysis buffer, and analyzed by Western 
blot.
1
 
 
Cross-linking experiments 
Formation of a complex between ZBTB17 (produced with an N-terminal His-tag in pET46 
vector and purified by standard nickel-affinity chromatography) and CSRP3 (MLP)
4
 was 
analyzed via cross-linking experiments with ethylene glycol bis(sulfosuccinimidylsuccinate)
4
 
(sulfo-EGS) (Thermo Scientific) solution in DMSO.  The experiment was performed in 40 µl 
reactions with increasing concentration of the crosslinker (0, 0.5, 1, 2, and 5 mM sulfo-EGS) and 
incubated for 15 to 30 min at room temperature. The reaction was quenched by addition of 1µl of 
1M tris(hydroxymethyl)aminomethane (Tris) buffer at pH8 and analyzed by SDS-PAGE. 
 
 
Adenoviral ZBTB17 constructs and analysis in vitro 
WT-ZBTB17 cDNA was cloned into recombinant human adenovirus 5 (Vector Biolabs). The 
effects of WT-ZBTB17 overexpression on hypertrophy and cell death were analyzed in neonatal 
rat cardiac myocytes (NRCM) using the xCELLigence Real-Time Cell Analyzer (RTCA; Roche 
Diagnostics Ltd.) or via cell surface area measurements. The xCELLigence system consists of a 
16-well E-plate with the bottom of each well covered by a gold microelectrode array. Electrical 
impedance (displayed as cell index) is directly proportional to the total area of the well that is 
covered by cells. Freshly isolated NRCMs in M-199 (Sigma) culture medium were plated at a 
density of 50,000 per well in a laminin-coated xCELLigence E-plate 16. A background reading 
is taken on the xCELLigence system prior to plating in the absence of cells. The xCELLigence 
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instrument is incubated at 37°C and 5% CO2 and the software programmed to take impedance 
measurements every 30 mins. 16-18 hrs after plating cells were infected with an adenovirus for 
either a GFP control or WT-ZBTB17. The effects of ZBTB17 overexpression were recorded for 
the following 48 hrs, an increase in cell index represents an increase in the area of the well 
covered by cells as these are non-proliferating cells any increase in cell index represents an 
increase in cell size. 48 hrs after adenoviral infection 1µM of DOX was added and cell index 
recorded for a further 48 hrs. Cell death was analyzed by normalizing the data to the point of 
addition of DOX and calculating the area under the curve (AUC), thus a larger AUC represents a 
slower rate of cell death. Staurosporin (SP) induced apoptosis was analyzed using fluorescence 
microscopy and DAPI staining (GenScript). NRCMs were infected with adenoviral constructs 
using 100 multiplicity of infection (MOI), for Western blot analysis cells were harvested after 48 
hrs. 
 
Generation of Zbtb17 conditional knock out animals, transgenic animals and TG-
ZBTB17/KO-Ppp3cb double transgenic animals 
Targeted deletion of Zbtb17 in cardiac tissue was accomplished by crossing mice expressing Cre 
recombinase under the control of the MLVC2 promoter as described previously
5
 into ZBTB17 
homozygous floxed (flox/flox) mice and backcrossing the resulting heterozygous mice governing 
the Cre recombinase back to homozygous Zbtb17 flox/flox, Cre
+
 mice. Cre mediated 
recombination resulted in deletion of the POZ domain. 
ZBTB17 transgenic (TG-ZBTB17) mice have been generated by overexpressing the human 
ZBTB17 cDNA under the control of the alpha myosin heavy chain promoter (αMHC). The 
transgene construct consists of the murine αMHC promoter, FLAG epitope tag, human ZBTB17 
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cDNA, and human growth hormone poly A signal. We established several lines overexpressing 
ZBTB17 at different expression levels. All experiments described here were performed with TG-
ZBTB17 line 10.  
 
TG-ZBTB17/KO-Ppp3cb double transgenic animals were generated by crossing TG-ZBTB17 
into Ppp3cb
-/-
 (kindly provided by Dr J. Molkentin
6
).  
 
Echocardiography and surgery 
Surgery was carried out using a modified minimally invasive approach as previously described
3
. 
Mice were anesthetized with Isoflurane and echocardiography was performed as described 
previously
3
. Briefly, transthoracic echocardiography was performed by an examiner blinded to 
the genotype of the animals using a Vevo2100 (VisualSonics) system with a 30 MHz centre 
frequency transducer. Two-dimensional cine loops with frame rates of >200 frames/s of a long 
axis view and a short axis view at mid-level of the papillary muscles as well as M-mode loops of 
the short axis view were recorded. 
 
Gene expression analyses in mouse hearts by qRT-PCR 
RNA from mouse left ventricles was extracted using the RNeasy Fibrous Tissue Mini Kit 
(Qiagen GmbH). For single qRT-PCR, reverse-transcription was performed from 500 ng total 
RNA using the iScript cDNA Synthesis Kit (Bio-Rad) according to the manufacturer´s 
instructions. PCR was performed in duplicate using the Bio-Rad iCycler (Bio-Rad) and SYBR 
Green as fluorescence. 
Submitted Manuscript:  Confidential      27 April 2015 
 
 
 
5 
 
For the SA Biosciences apoptosis gene expression array: RNA quantity and quality was assayed 
by the NanoDrop spectrometer and 1µg of the RNA was used for the cDNA synthesis with the 
reagents and primers provided (according to the manufacturer’s protocol, SA Biosciences). Gene 
expression of 84 key apoptosis genes was profiled by qRT-PCR based RT2 Profiler Apoptosis 
PCR Arrays (mouse: PAMM-012) using the RT2 SYBR Green/Rox Master mix. qRT-PCRs 
were performed in 96-well plate format using the ABI 7900 Fast Real-Time PCR System 
(Applied Biosystems). All data were analysed by RT2 Profiler Web-Based PCR Array Data 
Analysis (SA Biosciences). 
 
Immunofluorescence, Apoptosis, Immunolabelling and Cell Size Measurements 
Cryosections 5 µm thick were air dried and fixed with 4% paraformaldehyde (PFA). ZBTB17 
rabbit polyclonal primary antibody (Miz1, H-190; sc-22837, Santa Cruz, please see also 
Supplementary Table 7 for all antibodies used) was used. Phalloidin was purchased from Sigma 
and used to stain for F-actin; DAPI (nuclear staining) was purchased from Vector Laboratories 
2
. 
Apoptosis was analyzed using the “Roche - In Situ Cell Death Detection Kit, (Roche, 
#116847959110) according to the manufacturer’s instructions.  We used 6 WT and 6 Zbtb17 
conditional knockout hearts (cKO) after transverse aorta constriction (TAC) and results were 
averaged per mouse and expressed as apoptotic cells per mm². 
The quantification process was performed blinded to the type of section, having on the screen 
only one channel showing F-actin labeling. For each quantification, a specific setting was 
established and kept constant in all measurements. Quantification was performed by 
measurements of fluorescence intensity by using a range of 0 to 255 gray values. Arbitrary units 
of the fluorescence intensity were calculated per unit myocardial area (AU/mm
2
). The area of 
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collagen I were calculated as percent of positive labeling per tissue area. Primary antibody: 
biotinconjugated rabbit anti-collagen type I (Rockland), secondary detection system consisted of 
anti-mouse IgG and streptavidin linked Cy 3 (Amersham). 
Quantification of collagen I was performed as described previously
2
. In brief, cryosections from 
at least two different levels in each mouse were used. All samples were immunolabeled 
simultaneously with identical conditions of fixation and dilutions of primary and secondary 
antibodies. Sections exposed to PBS instead of primary antibodies served as negative controls. 
For each heart at least 10 random fields of vision were analyzed with a fluorescent microscope 
Leica (Leitz DMRB) using x40 Planapo objective (Leica). Immunolabeled cryosections were 
studied using image analysis (Leica) and Image J software (NIH).  
The quantification of Picrosirius Red stained (PSR) mouse heart cross sections was performed 
using Zen software (Zeiss) for x10 tile images and analysed the percentage of fibrosis area for 4 
random fields of each section by Fiji software.  
NRCM were infected in vitro with adenoviral WT-ZBTB17 for 48 hrs and cell surface areas 
were measured using Image J software. 
Cardiomyocyte cross-sectional area in vivo was determined at the nuclear level in 100 - 150 
cardiomyocytes with clearly defined cellular borders as determined by dystrophin 
immunolabeling (H-300, Santa Cruz Biotechnology). 
Three-dimensional co-localization analysis was performed using the co-localization module of 
Imaris®, version 7.3 (Bitplane, Zürich, Switzerland). 
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Calcineurin promoter and calcineurin/NFAT pathway analysis  
NFAT activity in cardiomyocytes was measured using a Gal4-NFAT chimera.
7, 8
 NRCMs were 
isolated as previously described.
9
 Cells were transfected for 6 hrs in serum-free DMEM using 
Lipofectamine 2000 (Invitrogen) together with a vector expressing a chimeric construct of the 
DNA binding domain of the yeast transcription factor Gal4 linked to the transcription activation 
domain of NFAT; a reporter plasmid in which luciferase expression is controlled by four Gal4 
responsive sites (UAS) and a WT pcDNA3.1-ZBTB17 expression vector. Empty pcDNA3.1 was 
used as a negative control for ZBTB17. Medium was replaced after transfection and cells were 
lysed 48 hrs later. Luciferase activity was measured using a commercial kit (Promega). 
 
ChIP - chip  
ChIP-chip analysis was performed using ChIP-chip 3x720K RefSeq Promoter Assay (Roche, 
genome build mm9). ChIP samples were prepared using the Zbtb17 specific antibody (Miz1, 
H190, sc22837X, Santa Cruz) and 25 mg of mouse heart combined with Dynabeads sheep anti-
rabbit IgG (Life Technology; Nimblegen ChIP-chip service protocol). The hybridization and 
scanning step were performed by Roche Nimblegen Array Service. Peaks of ChIP-enriched 
sequences were calculated by log2 (ChIP/input) method and the FDR value were calculated by 
NimbleScan software (Nimblegen system). The peak data was analyzed by SignalMap version 
1.9 (Nimblegen system) software. 
Statistical analysis 
Student t-test and 2-tailed P-values were used for comparing groups unless otherwise indicated. 
Data were formatted in MS Excel and statistical analyses were carried out using SPSS v20 (IBM 
SPSS statistics). Unless otherwise indicated data are reported as means ± S.D.  
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Supplemental Figure 1. Co-localization of Zbtb17 and Csrp3 in the nuclear compartment 
of the mouse cardiac myocytes  
(A) Representative confocal images of Zbtb17 and Csrp3 in WT mouse heart samples. 
Arrows indicate typical cardiomyocyte nuclei that are positive for both, Zbtb17 and 
Csrp3. Lower left panel is the three-dimensional image of the boxed region (left middle 
panel). Shown in the lower right panel is a three-dimensional co-localized color (in 
intensity units, from blue color as the lowest value and white color, as the highest value) 
of Zbtb17 with Csrp3. The mean percentage of co-localization of ROI (nucleus) of 
Zbtb17 with Csrp3 was 83.8 ± 3.4 (n = 5 WT hearts, 148 ± 5.1 nuclei per each heart 
tissue sample). The mean Pearson’s coefficient in co-localized volume was 0.9019 ± 
0.0024. (B) Csrp3 knockout hearts are used as negative controls (arrows indicate Zbtb17 
in cardiac myocytes). (C) cKO hearts are used as negative controls (arrowheads indicate 
Zbtb17 in non-cardiac myocytes and arrows indicate Csrp3 in cardiac myocytes). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Submitted Manuscript:  Confidential      27 April 2015 
 
 
 
10 
 
Supplemental Figure 2. ZBTB17 overexpression in NRCM results in marked hypertrophy  
(A) Adenoviral overexpression of WT-ZBTB17 for 48 hrs results in marked hypertrophy in 
NRCM as measured by cell surface area (AdLacZ 1.0 ± 0.020 n = 653; AdWT-ZBTB17 
1.35 ± 0.025 n = 589; 3 independent experiments). (B) ZBTB17 overexpression protects 
NRCM from SP induced apoptosis. Three different experiments were performed (1µM of 
SP for 24 hrs, AdLacZ 1.0 ± 0.02, n = 653 cells; AdZBTB17 1.4 ± 0.03, n = 589 cells; 
*p<0.05; ***p<0.001).  
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Supplemental Figure 3. Characterization of cKO-Zbtb17 animals  
(A) MLC2V–Cre mediated recombination efficiency as determined by Southern blot analysis 
using genomic DNA derived from myocardial tissue. The three lanes on the right side of 
the gel marked: “f/f, Cre+” (cKO) where floxed recombined and floxed alleles can be 
compared to each other. It can be estimated that recombination occurred in at least 20% 
of the cells, which indicates relatively high recombination efficiency in the cardiac 
myocyte population (M: marker) (upper panel). MLC2V–Cre mediated recombination 
efficiency as determined by Southern blot analysis using genomic DNA derived from 
isolated cardiac myocytes and non-myocytes. We observed much stronger signals for the 
floxed, recombined allele in case of cardiac myocytes isolated from homozygous 
knockout animals (f/f, Cre
+
) when compared to the low-level background recombination 
occurring in non-myocytes (the fibroblast fraction might not be absolutely pure, a few 
cardiac myocytes might have been present) (lower panel). (B) Efficiency of the MLC2V–
Cre mediated recombination as determined by qRT-PCR. We amplified the Cre deleted 
part of the ZBTB17 gene in control (+/+, Cre
-
; n = 4), heterozygous (f/+, Cre
+
; n = 1) and 
homozygous knockout animals (f/f, Cre
+
; n = 9). There is a significant loss of this 
genomic region in the homozygous knockout animals. (C) MLC2V–Cre mediated 
recombination efficiency as determined by immunohistochemistry staining. There is a 
significant loss of Zbtb17 expression in cardiac myocyte nuclei in cKO animals (red: F-
actin; green: Zbtb17; blue: DAPI). (D) Western blot analysis of Zbtb17 protein 
expression in cKO-Zbtb17 animals. (E) Analysis of apoptosis via TUNEL assay and 
caspase 3 positivity (pink: TUNEL positive nuclei; DAPI: nuclear staining; red: caspase 
3; green: F-actin). 
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Supplemental Figure 4. Characterization of TG-ZBTB17 animals  
(A) Western blot analysis of ZBTB17 in ZBTB17 transgenic animals. The FLAG tagged 
transgenic protein has a slightly higher molecular mass than the endogenous ZBTB17 
protein (upper panel). Quantification of Western blot analysis (WT: wildtype, TG: 
transgenic, n = 3 per group, data normalized to GAPDH expression; *p<0.05) (lower 
panel). (B) Fibrosis as determined by PSR staining in TG-ZBTB17 animals. (C) ZBTB17 
protein localization in FLAG tagged TG-ZBTB17 animals. FLAG-tagged ZBTB17, like 
endogenous Zbtb17, localizes to cardiac myocyte nuclei. (D) Negative control (red: anti-
FLAG antibody; green: F-actin, blue: DAPI (nuclear staining). All experiments were 
performed using TG-ZBTB17 line 10. 
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Supplemental Figure 5. Ppp3cb and Nfatc2 mRNA expression in cKO  
(A) Decreased Ppp3cb and Nfatc2 mRNA expression levels in cKO (experiments were 
performed twice, n = 3 per group)  
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Supplemental Table 1. Echocardiography of TG-ZBTB17/KO-Ppp3cb animals 
Echocardiography 
LVID;s 
(mm) 
LVID;d 
(mm) 
EF 
(%) 
LV Wall mass/BW 
(mg/g) 
WT-ZBTB17 
(n=5) 
2.56 3.61 57.02 3.36 
TG-ZBTB17 
(n=11) 
1.99* 3.44 73.76** 4.87* 
TG-ZBTB17/KO-Ppp3cb 
(n=5) 
2.01 3.53 74.98
†
 3.18
#
 
 
Analysis of the spontaneous phenotype of TG-ZBTB17 and TG-ZBTB17/KO-Ppp3cb double 
transgenic animals by echocardiography (*P < 0.05, **P < 0.01 vs WT-ZBTB17; †P < 0.05 vs 
WT-ZBTB17, 
#
P< 0.05 vs TG-ZBTB17). 
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Supplemental Table 2. List of primers used in this study 
Gene name Primer name 
 
Primer sequence Description 
Ppp3cb mCnAβ-forward tgg gat acc cag ggt tga tg qRT-PCR 
mCnAβ-reverse 
 
aat tgg cca tgg atg tca cc qRT-PCR 
Ppp3cb 
promoter 
m_ppp3cb_pro_F gagtgactggctgcctcc ChIP-qPCR  
m_ppp3cb_pro_R 
 
cacaggcaaagcaggaaaga ChIP-qPCR 
Nfatc2 mNFATc2-forward ggg ttc ggt gag tga cag tt qRT-PCR 
mNFATc2-reverse 
 
cag gaa ggc act tgg gta aa  qRT-PCR 
Zbtb17 miz1-P3-forward cgt tga ctt caa ggc tca ca qRT-PCR 
miz1-P4-reverse 
 
cgt cca cgt tct cag ggc taa qRT-PCR 
Nppa RT-m-anf-F acctgctagaccacctggaggag qRT-PCR 
RT-m-anf-R ccttggctgttatcttcggtaccg qRT-PCR 
Gapdh 
 
 
mGAPDH-F cgtcccgtagacaaaatggt qRT-PCR 
mGAPDH-R 
 
ttgatggcaacaatctccac qRT-PCR 
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Supplemental Table 3. Primary antibodies used in this study 
Primary Antibodies 
 
Companies (Catalogue #) 
Caspase 3 (polyclonal) 
 
Cell Signalling (#9661) 
Collagen I (polyclonal) 
 
Rockland (600-401-103-0.5) 
Csrp 3/Mlp (polyclonal) 
 
Santa Cruz Biotechnology (sc-30274) 
DAPI (nuclear staining) 
 
Vector Laboratories (H-1200) 
Dystrophin (H-300) 
 
Santa Cruz Biotechnology (sc-15376) 
F-actin (Phalloidin) 
 
Sigma (P1951) 
anti-FLAG (monoclonal) 
 
Sigma (F3165) 
Miz1 (H-190) 
 
Santa Cruz Biotechnology (sc-22837) 
GAPDH Sigma (9545) 
 
Kir2.1 Santa Cruz Biotechnology (sc-28633) 
 
alpha-actinin (monoclonal, clone EA.53) Sigma (A7811 ) 
 
Telethonin (G-11) Santa Cruz Biotechnology (sc-25327) 
 
 
 
